ClarIDHy: A phase 3, multicenter, randomized, double-blind study of AG-120 vs placebo in patients with an advanced cholangiocarcinoma with an IDH1 mutation Meeting Abstract
| Authors: | Lowery, M. A.; Abou-Alfa, G. K.; Valle, J. W.; Kelley, R. K.; Goyal, L.; Shroff, R. T.; Javle, M. M.; Borad, M. J.; Cleary, J. M.; El-Khoueiry, A. B.; Bendell, J. C.; Macarulla, T.; Vogel, A.; Korth, C.; Jiang, L.; Gliser, C.; Wu, B.; Agresta, S. V.; Pandya, S. S.; Zhu, A. X. |
| Abstract Title: | ClarIDHy: A phase 3, multicenter, randomized, double-blind study of AG-120 vs placebo in patients with an advanced cholangiocarcinoma with an IDH1 mutation |
| Meeting Title: | 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 35 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2017 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2017-05-20 |
| Start Page: | 233s |
| Language: | English |
| ACCESSION: | WOS:000411931700004 |
| DOI: | 10.1200/JCO.2017.35.15_suppl.TPS4142 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS4142 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
